Evdoxia Eirini Lithoxoidou

Evdoxia Eirini Lithoxoidou

Auto-generated profile, based on publicly available information

Evdoxia Eirini Lithoxoidou

Information Technologies Institute, Centre for Research and Technology Hellas, 57001 Thessaloniki, Greece

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 March 2025
Verified
Conference Paper
Open access
ELEvdoxia Eirini Lithoxoidou
Evdoxia Eirini Lithoxoidou
GEGeorge Eleftherakis
George Eleftherakis
KVKonstantinos Votis
Konstantinos Votis
TPTony J. Prescott
Tony J. Prescott

24 December 2025 in Healthcare
Verified
Journal Article
Open access
PDF file
ATAndreas Triantafyllidis
Andreas Triantafyllidis
SSSofia Segkouli
Sofia Segkouli
SKStelios Kokkas
Stelios Kokkas
AAAnastasios Alexiadis
Anastasios Alexiadis
ELEvdoxia Eirini Lithoxoidou
Evdoxia Eirini Lithoxoidou
DTDimitrios Tzovaras
Dimitrios Tzovaras
Background/Objective: The use of Large Language Models (LLMs) has recently gained significant interest from the research community toward the development and adoption of Generative Artificial Intelligence (GenAI) solutions for healthcare. The present work introduces the first meta-review (i.e., review of systematic reviews) in the field of LLMs for chronic diseases, focusing particularly on cardiovascular, cancer, and mental diseases, to identify their value in patient care, and challenges for their implementation and clinical application. Methods: A literature search in the bibliographic databases of PubMed and Scopus was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, to identify systematic reviews incorporating LLMs. The original studies included in the reviews were synthesized according to their target disease, specific application, LLMs used, data sources, accuracy, and key outcomes. Results: The literature search identified 5 systematic reviews respecting our inclusion and exclusion criteria, which examined 81 unique LLM-based solutions. The highest percentage of the solutions targeted mental disease (86%), followed by cancer (7%) and cardiovascular disease (6%), implying a large research focus in mental health. Generative Pre-trained Transformer (GPT)-family models were used most frequently (~55%), followed by Bidirectional Encoder Representations from Transformers (BERT) variants (~40%). Key application areas included depression detection and classification (38%), suicidal ideation detection (7%), question answering based on treatment guidelines and recommendations (7%), and emotion classification (5%). Study aims and designs were highly heterogeneous, and methodological quality was generally moderate with frequent risk-of-bias concerns. Reported performance varied widely across domains and datasets, and many evaluations relied on fictional vignettes or non-representative data, limiting generalisability. The most significant found challenges in the development and evaluation of LLMs include inconsistent accuracy, bias detection and mitigation, model transparency, data privacy, need for continual human oversight, ethical concerns and guidelines, as well as the design and conduction of high-quality studies. Conclusions: While LLMs show promise for screening, triage, decision support, and patient education—particularly in mental health—the current literature is descriptive and constrained by data, transparency, and safety gaps. We recommend prioritizing rigorous real-world evaluations, diverse benchmark datasets, bias-auditing, and governance frameworks before LLM clinical deployment and large adoption.

16 June 2022
Verified
Book Chapter
Closed access
PDF file
ELEvdoxia-Eirini Lithoxoidou
Evdoxia-Eirini Lithoxoidou
RMRafail-Evangelos Mastoras
Rafail-Evangelos Mastoras
APAris Papaprodromou
Aris Papaprodromou
CGCharalampos Georgiadis
Charalampos Georgiadis
PJPatricia Abril Jimenez
Patricia Abril Jimenez
DTDimitrios Tzovaras
Dimitrios Tzovaras

31 October 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
ATAndreas Triantafyllidis
Andreas Triantafyllidis
SSSofia Segkouli
Sofia Segkouli
SKStelios Kokkas
Stelios Kokkas
AAAnastasios Alexiadis
Anastasios Alexiadis
ELEirini Lithoxoidou
Eirini Lithoxoidou
DTDimitrios Tzovaras
Dimitrios Tzovaras
Background/Objective: The use of Large Language Models (LLMs) has recently gained significant interest from the research community toward the development and adoption of Generative Artificial Intelligence (GenAI) solutions for healthcare. The present work introduces the first meta-review (i.e., review of systematic reviews) in the field of LLMs for chronic diseases, focusing particularly on cardiovascular, cancer, and mental diseases, with the goal to identify their value in patient care, as well as challenges for their implementation and clinical application. Methods: A literature search in the bibliographic databases of PubMed and Scopus was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, in order to identify systematic reviews incorporating LLMs. The original studies included in the reviews were synthesized according to their target disease, specific application, used LLMs, data sources, accuracy, and key outcomes. Results: The literature search identified 5 systematic reviews respecting our inclusion and exclusion criteria, which examined 81 unique LLM-based solutions. The highest percentage of the solutions targeted mental disease (70 studies, 86%), followed by cancer (6 studies, 7%) and cardiovascular disease (5 studies, 6%). Generative Pre-trained Transformer (GPT) models were used in most studies (45 studies, 55%), followed by Bidirectional Encoder Representations from Transformers (BERT) models (33 studies, 40%). Key application areas included depression detection and classification (31 studies, 38%), suicidal ideation detection (6 studies, 7%), question answering based on treatment guidelines and recommendations (6 studies, 7%), and emotion classification (4 studies, 5%). Studies were highly heterogeneous, with most studies (41 studies, 50%) focusing on clinical/diagnostic accuracy using metrics for correct diagnosis, agreement with guidelines or model performance, whereas other studies (34 studies, 42%) were descriptive and focused on narrative outcomes, usability, trust or plausibility. The most significant found challenges in the development and evaluation of LLMs include inconsistent accuracy, bias detection and mitigation, model transparency, data privacy, need for continual human oversight, ethical concerns and guidelines, as well as the design and conduction of high-quality studies. Conclusion: The results of this review suggest LLMs could become valuable tools for enhancing diagnostic precision and decision support in cardiovascular disease, cancer and mental health . Given the limited number of studies included in this review and their moderate quality, we urge the research community to conduct more investigations in real-world intervention settings to better demonstrate the clinical utility of LLMs.

16 April 2026 in Computers & Education: X Reality
Verified
Journal Article
Open access
ICIlias Chrysovergis
Ilias Chrysovergis
ELEvdoxia Eirini Lithoxoidou
Evdoxia Eirini Lithoxoidou
DPDimitris Pallantzas
Dimitris Pallantzas
TTThanos Tsakiris
Thanos Tsakiris
DIDimosthenis Ioannidis
Dimosthenis Ioannidis
DTDimitrios Tzovaras
Dimitrios Tzovaras

27 May 2026
Verified
Book Chapter
Closed access
ELEvdoxia Eirini Lithoxoidou
Evdoxia Eirini Lithoxoidou
Stylianos KrinidisStylianos Krinidis
Stylianos Krinidis
PRPolyvios Raxis
Polyvios Raxis
Vasiliki DrougaVasiliki Drouga
Vasiliki Drouga
DIDimosthenis Ioannidis
Dimosthenis Ioannidis
DTDimitrios Tzovaras
Dimitrios Tzovaras